Bloomberg View: A Pricey Weapon to Fight AIDS
Public health experts gained another weapon in their battle against AIDS when the U.S. Food and Drug Administration approved an HIV drug for preventive use. This will help pave the way for its authorization in developing countries. The drug, called Truvada, is expensive, but it could do considerable good in Africa if deployed smartly.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.